Launches of New Medicines in Canada Declined Consistently in Recent Years: New Data

Canadians waiting longer for new treatments as Canada slips from its traditional position as a top-priority country for new medicine launches TORONTO–(BUSINESS WIRE)–The launches of new medicines in Canada declined consistently and markedly in Canada over the past five years as ongoing changes to the pharmaceutical policy environment, including federal medicine pricing reforms (i.e., PMPRB … [Read more…]

Argentina CBD and Cannabis Market Regulations Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Argentina: CBD and Cannabis Regulation” report has been added to ResearchAndMarkets.com’s offering. This report offers a comprehensive overview of the current regulatory framework for hemp, CBD, and cannabis (medical and recreational) covering all areas from processing and cultivation to finished products, extracts, and imports/exports. Despite its long-lasting restrictive approach towards cannabis and cannabis-derived … [Read more…]

EU Regulatory Report 2022: The Kanavape Ruling’s Impact on EU Harmonization of CBD – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: The Kanavape Ruling’s Impact On EU Harmonization Of CBD” report has been added to ResearchAndMarkets.com’s offering. Since the publishing of the Kanavape decision in November 2020, some EU member states are still non-compliant with it, and a number of member states still view as illegal CBD-containing vape products, hemp flowers, and … [Read more…]

aequum LLC Advises Annual Enrollment Should Start Now: Be Proactive…as Passive Enrollment is so Passé

CLEVELAND–(BUSINESS WIRE)–#HR—aequum LLC, acting on behalf of 325 self-insured health plans and their participants, recommends that employers with a calendar year plan year begin preparing for annual enrollment now. Employers who offer a choice of coverage options may be able to improve associate engagement by replacing a passive enrollment approach with an active enrollment strategy. … [Read more…]

  Amidst America’s Mental Health Crisis, 60% of Employees Are Not Utilizing Mental Health Coverage

Lively’s Third Annual Wellness and Wealth Report Shows The Impact of Economic Uncertainty, Rising Healthcare Costs and Inflation SAN FRANCISCO–(BUSINESS WIRE)–#HSA—Lively, Inc., Lively, the top-rated benefit solutions provider known for creating the modern Health Savings Account (HSA), today released its third annual Wellness & Wealth Report giving a view into American healthcare trends for employers … [Read more…]

Imagia Canexia Health Achieves First CE-IVD Status in the E.U. to Deploy Comprehensive Cancer Testing Platform

The Imagia Canexia Health Insights Platform (ICHIP), which provides cancer-treatment analysis directly to local oncologists, is now available across Europe MONTRÉAL–(BUSINESS WIRE)–#cancer—Imagia Canexia Health, a genomics-based cancer treatment testing company that accelerates access to precision care by combining AI expertise with advanced molecular biopsy solutions, today announced the CE-IVD marking for its Imagia Canexia Health … [Read more…]

Global Clinical Trials Support Services Market Report 2022-2030: Clinical Trial Site Management & Patient Recruitment Management – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Clinical Trials Support Services Market Size, Share & Trends Analysis Report by Service (Clinical Trial Site Management, Patient Recruitment Management), by Phase, by Sponsor, by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global clinical trials support services market is expected to reach USD 37.1 billion by 2030, … [Read more…]

Global Soft Tissue Biologics Market Research Report 2022: Size, Segments, Share, Trends, SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Soft Tissue Biologics Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering. The model discusses in detail the impact of COVID-19 on Soft Tissue Biologics Devices market for the year 2020 and beyond. Orthopedic soft … [Read more…]

epocrates Appoints New Leaders to Guide Commercial Strategy, Consulting, and Customer Experience Amidst New Wave of Growth

Additions of Andrew Johnson and Bridget Seay strengthen epocrates’ evolution as a commercial organization with best-in-class market intelligence and products WATERTOWN, Mass.–(BUSINESS WIRE)–epocrates, an athenahealth, Inc. company that delivers digital clinical decision support to prescribers, today announced the expansion of its commercial leadership team to drive the enhancement and development of the company’s commercial product … [Read more…]

Paige Announces Collaboration to Deploy a Novel AI-Based Biomarker Test for Advanced Bladder Cancer in Clinical Settings

Paige and Janssen will collaborate to deploy an AI-powered, H&E-based biomarker test, developed by Janssen, to screen for actionable FGFR2 and FGFR3 genomic alterations within seconds Goal is to provide physicians with important insights to help tailor patients’ treatment plans and facilitate clinical trial recruitment NEW YORK–(BUSINESS WIRE)–Paige, a global leader in clinical AI applications … [Read more…]